Significant Ownership of Bios Equity Partners, LP

Signature - Title: John Fucci - Attorney-in-Fact
Location: Fort Worth, TX
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Bios Equity Partners, LP.

Notify me when Bios Equity Partners, LP files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
LTRN	Lantern Pharma Inc.	Common Stock, par value $0.0001 per share	10%	$4,153,175		1,075,952		CAVU MANAGEMENT, LP	12 Jun 2025

Schedules 13D/G Reported by Bios Equity Partners, LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.